Serum copeptin was higher in CF patients during pulmonary exacerbation than in stable condition (649.74 ± 980.78 [pg/mL] vs. 487.76 ± 365.7 [pg/mL]; p = 0.58), though none of the differences reached statistical significance. Here, AVP is linked to cystic fibrosis.